TY - JOUR
T1 - Screening digital rectal examination and prostate cancer mortality
T2 - A population-based case-control study
AU - Jacobsen, Steven J.
AU - Bergstralh, Erik J.
AU - Katusic, Slavica K.
AU - Guess, Harry A.
AU - Darby, Charles H.
AU - Silverstein, Marc D.
AU - Oesterling, Joseph E.
AU - Lieber, Michael M.
N1 - Funding Information:
This study was supported, in part, by grant AR30582 from the U.S. Public Health Service, National Institutes of Health.
PY - 1998/8
Y1 - 1998/8
N2 - Objectives. Although digital rectal examination (DRE) for the detection of prostate cancer has been recommended by many professional groups and has become part of the general physical examination, no randomized clinical trial has demonstrated the efficacy or effectiveness of this practice. We conducted a population-based case-control study to evaluate the association between DRE and prostate cancer mortality. Methods. With the resources of the Rochester Epidemiology Project, all 173 men who died of prostate cancer in Olmsted County from 1976 to 1991, who were resident at the time of diagnosis, were identified. For each case, two control patients were drawn from the population, matched for residence at the time of diagnosis in the case, birth date; and duration of medical record in Olmsted County. Trained nurse abstractors reviewed the community medical records for up to 10 years before the date of diagnosis in the case for mention of DRE and specific findings associated with each mention. Results. Case subjects were less likely than control subjects to have had any DRE in the 10 years before diagnosis (matched odds ratio [OR] = 0.51; 95% confidence interval [CI] = 0.31, 0.84). When limited to DREs without mention of signs or symptoms that might raise suspicion of prostate cancer, the association was even stronger (OR = 0.31; 95% CI = 0.19, 0.49). Adjustment for educational attainment, marital status, and comorbid conditions did little to alter the associations. Conclusions. These results demonstrate a strong inverse association between DRE and prostate cancer mortality. If further research concludes this association to be causal, screening DREs may have prevented as many as 50% to 70% of deaths due to prostate cancer that might have occurred in the absence of screening.
AB - Objectives. Although digital rectal examination (DRE) for the detection of prostate cancer has been recommended by many professional groups and has become part of the general physical examination, no randomized clinical trial has demonstrated the efficacy or effectiveness of this practice. We conducted a population-based case-control study to evaluate the association between DRE and prostate cancer mortality. Methods. With the resources of the Rochester Epidemiology Project, all 173 men who died of prostate cancer in Olmsted County from 1976 to 1991, who were resident at the time of diagnosis, were identified. For each case, two control patients were drawn from the population, matched for residence at the time of diagnosis in the case, birth date; and duration of medical record in Olmsted County. Trained nurse abstractors reviewed the community medical records for up to 10 years before the date of diagnosis in the case for mention of DRE and specific findings associated with each mention. Results. Case subjects were less likely than control subjects to have had any DRE in the 10 years before diagnosis (matched odds ratio [OR] = 0.51; 95% confidence interval [CI] = 0.31, 0.84). When limited to DREs without mention of signs or symptoms that might raise suspicion of prostate cancer, the association was even stronger (OR = 0.31; 95% CI = 0.19, 0.49). Adjustment for educational attainment, marital status, and comorbid conditions did little to alter the associations. Conclusions. These results demonstrate a strong inverse association between DRE and prostate cancer mortality. If further research concludes this association to be causal, screening DREs may have prevented as many as 50% to 70% of deaths due to prostate cancer that might have occurred in the absence of screening.
UR - http://www.scopus.com/inward/record.url?scp=0032145984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032145984&partnerID=8YFLogxK
U2 - 10.1016/S0090-4295(98)00171-X
DO - 10.1016/S0090-4295(98)00171-X
M3 - Article
C2 - 9697778
AN - SCOPUS:0032145984
SN - 0090-4295
VL - 52
SP - 173
EP - 179
JO - Urology
JF - Urology
IS - 2
ER -